EGFR and non-small cell lung carcinoma: An anti-EGFR scFv was fused to the plant toxin gelonin (rGel) to get a targeted toxin, which could selectively bind EGFR-overexpressing cells with high affinity and significantly suppressed the tumor growth of human NSCLC (49).